tiprankstipranks
Dynavax sees 2024 Heplisav-B product revenue $265M-$280M
PremiumThe FlyDynavax sees 2024 Heplisav-B product revenue $265M-$280M
2M ago
Dynavax reports Q4 EPS 0c, consensus (1c)
PremiumThe Fly
Dynavax reports Q4 EPS 0c, consensus (1c)
2M ago
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Qualcomm downgraded, Cigna upgraded: Wall Street’s top analyst calls
3M ago
Dynavax price target raised to $27 from $25 at JMP Securities
PremiumThe FlyDynavax price target raised to $27 from $25 at JMP Securities
6M ago
Dynavax price target raised to $28 from $27 at H.C. Wainwright
PremiumThe Fly
Dynavax price target raised to $28 from $27 at H.C. Wainwright
6M ago
Dynavax raises 2023 Heplisav-B revenue to $210M-$220M from $200M-$215M
PremiumThe Fly
Dynavax raises 2023 Heplisav-B revenue to $210M-$220M from $200M-$215M
6M ago
Dynavax price target raised to $25 from $24 at JMP Securities
PremiumThe FlyDynavax price target raised to $25 from $24 at JMP Securities
9M ago
Dynavax files automatic mixed securities shelf
PremiumThe Fly
Dynavax files automatic mixed securities shelf
9M ago
Dynavax raises FY23 HEPLISAV-B net product revenue outlook to $200M-$215M
PremiumThe Fly
Dynavax raises FY23 HEPLISAV-B net product revenue outlook to $200M-$215M
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100